Summary The human multidrug resistance protein (MRP1) confers resistance of cells to a number of different cytostatic drugs and functions as an export pump for glutathione S-conjugates, glucuronides and other amphiphilic anions. The present study details for the first time MRP1 -mediated ATP-dependent transport of various glutathione S-conjugates of the bifunctional alkylating agents chlorambucil and melphalan. In membrane vesicles prepared from cells expressing recombinant MRP1, the conjugates were transported at rates in the following order: monoglutathionyl chlorambucil > bisglutathionyl chlorambucil > monohydroxy monoglutathionyl chlorambucil and monoglutathionyl melphalan > monohydroxy monoglutathionyl melphalan. In addition, we show that membranes from chlorambucil-resistant GST-a-overexpressing CHO cells as well as from their parental cells express the hamster homologue of MRP1. With both CHO cell membrane preparations, we observed ATP-dependent transport of monoglutathionyl chlorambucil and of leukotriene C4, a glutathione S-conjugate and high-affinity substrate of MRP1. The transport rates measured in the resistant cells were only two-to three-fold higher than those measured in the control cells. These results together with cytotoxicity assays comparing MRP1-overexpressing cell pairs with the CHO cell pair indicate that, although MRP1-mediated transport is active, it may not be the rate-limiting step in chlorambucil resistance in these cell lines.
The multidrug resistance protein (MRP1) has been shown to be an ATP-dependent export pump for amphiphilic conjugates, including several glutathione S-conjugates, such as the highaffinity endogenous substrate leukotriene C4 (LTC4) (Jedlitschky et al, 1994 ; Leier et al, 1994a; Muller et al, 1994) , oxidized glutathione (GSSG) and xenobiotic conjugates such as S-(2,4-dinitrophenyl)glutathione (Leier et al, 1994a; Jedlitschky et al, 1994; Muller et al, 1994) and monoglutathionyl melphalan . In addition, MRP1 substrates include a number of sulphated and glucuronidated compounds , Loe et al, 1996a .
Melphalan and chlorambucil are bifunctional alkylating agents commonly used in the treatment of several types of cancers (Terenbaum, 1994) . Acquired resistance, however, often hinders the success of chemotherapy. It is known that resistance to alkylating agents is associated with increased glutathione levels and GST activity (Hayes and Pulford, 1995; O'Brien and Tew, 1996) . The a-isoform of the glutathione transferases (GST), the most efficient enzyme catalysing the glutathione conjugation to these drugs, has been isolated and purified from cell lines selected for resistance to melphalan or chlorambucil, as well as from human and mouse liver cytosol and from human kidney cytosol (Lewis et al, 1988; Ciaccio et al, 1990; Meyer et al, 1993) . In addition, the glutathione S-conjugates of both drugs have been characterized by fast atom bombardment mass spectrometry (Dulik et al, 1986 (Dulik et al, , 1990 .
In this study, the transport of the different glutathione S-conjugates of these alkylating agents into membrane vesicles prepared from MRPI-transfected and control HeLa cells was determined. Interestingly, we found that the hamster homologue of MRP1 (termed as Mrpl in rodents) is expressed in membranes from chlorambucil-resistant CHO cells that overexpress GST-a as well as in control CHO-KI cells. We therefore examined the transport of LTC4 and monoglutathionyl chlorambucil in these membranes. Materials [14, 15, 19, LTC4 (4.7 TBq mmol-') and [glycine-2-3H]-glutathione (1.7 TBq mmol-') were purchased from DuPont New England Nuclear (Boston, MA, USA). [G-3H] Chlorambucil (180 GBq mmol-1) and [chloroethyl-1,2-14C]melphalan (1.85 GBq mmol-1) were obtained from Moravek Biochemicals (Brea, CA, USA). Unlabelled LTC4 and the enhanced chemiluminescence (ECL) detection kit were from Amersham-Buchler (Braunschweig, Germany) . Unlabelled chlorambucil, melphalan and glutathione (GSH) were from Sigma Chemical (St Louis, MO, USA). Nickspin columns filled with Sephadex G-50 fine were obtained from Pharmacia-LKB (Freiburg, Germany) and nitrocellulose filters from Schleicher & Schull (Dassel, Germany).
MATERIALS AND METHODS

Cells
The cell lines HeLa (human cervix carcinoma cell line), HL60 (human promyelocytic leukaemia), and GLC4 (human small lung cell carcinoma) were cultured in RPMI medium supplemented with 10% fetal calf serum (FCS), 100 IU ml-' penicillin/streptomycin and 10 gIM a-thioglycerol. The drug-selected MRPl-overexpressing HL60/ADR cells were kept in the presence of 200 nm daunorubicin (Krishnamachary and Center, 1993) and the GLC4/ADR cells in the presence of 1.2 gM doxorubicin (Zijlstra et al, 1987) . The MRPJ- transfected HeLa T5 and the control vector-transfected HeLa Cl cells (kindly provided by Drs RG Deeley and SPC Cole, Kingston, Ontario, Canada) were kept under their selection agent geneticin (600,M) (Cole et al, 1994) . The chlorambucil-resistant GST-a overexpressing CHO-Chlr (Chinese hamster ovary) and control CHO-Kl cells (kindly provided by Dr A Hall, Newcastle, UK) were grown in FIO (Ham) medium containing 10% FCS and 100 IU ml-1 penicillin/streptomycin (Robson et al, 1986 (Akerboom and Sies, 1994) ; this was done to avoid the synthesis of mixed disulphides between GSH and DTT. All incubations were terminated and protein was precipitated by addition of ice-cold ethanol at a final concentration of 75% (v/v). This mixture was kept for at least 2 h at -20°C before centrifugation and high-performance liquid chromatography (HPLC) separation.
Chlorambucil glutathione S-conjugates were purified using a two-step RP-HPLC procedure with a C18 Hypersil column. Flow rates were set at 1 ml min-'. In step one, buffer A consisted of 5 mM ammonium acetate in water pH 5.7 and buffer B of 5 mm ammonium acetate in 80% methanol pH 5.7. The column was equilibrated with buffer A. From 5 to 50 min, a linear gradient ran from 50% A/50% B to 100% B followed by 10 min with buffer B. In this first step, bisglutathionyl chlorambucil and monohydroxy monoglutathionyl chlorambucil were eluted in one peak. These conjugates were then separated with the second HPLC system. Buffer A was composed of 0.065% trifluoracetic acid (TFA) in water and buffer B of 0.05% TFA in 80% acetonitrile. Equilibration of the column with buffer A was followed by a 30-min linear gradient to 75% A/25% B, which then ran with this solvent mixture isocratically for 10 min.
Monoglutathionyl melphalan and monohydroxy monoglutathionyl melphalan were purified by RP-HPLC with a C,8 Hypersil column with the following solvent system: buffer A was composed of 0.1% acetic acid in water pH 5.7 and buffer B 0.1% acetic acid in 38% acetonitrile pH 5.7. The column was equilibrated with buffer A followed by a 35-min linear gradient to 100% B. Buffer B then ran isocratically for 15 min.
Electrospray ionization mass spectrometry (ESI-MS)
Electrospray mass spectra were recorded on a Finnigan MAT TSQ 7000 triple quadrupole mass spectrometer (Palo Alto, CA, USA) equipped with an ESI ion source (Fenn et al, 1988; Voyksner, 1992) . The standard spray needle assembly was replaced by a nanoelectrospray ion source (The Protein Analysis Company, Odense, Denmark) (Wilm and Mann, 1996 Transport studies with membrane vesicles Membrane vesicles were prepared as described previously (Leier et al, 1994b) . The ATP-dependent transport of radioactively labelled chlorambucil, melphalan and their glutathione S-conjugates into inside-out membrane vesicles was measured using the Nickspin column filtration method essentially as described (Bohme et al, 1993; Biichler et al, 1994) . In brief, the radioactive substrates were incubated in the presence of 4 mm ATP or 4 mM AMP-PCP, an ATP-regenerating system, and 15 jg of membrane protein per 55 gl assay volume in an incubation buffer containing 250 mM sucrose and 10 mM Tris-HCl, pH 7.4 at 37°C. In addition, [3H] chlorambucil transport was tested in the presence of 10 mm GSH in the incubation medium according to measurements described by Loe et al (1996b) . Aliquots were taken and the reaction was stopped by direct deposit on the Nick-spin column cooled to 4°C, columns were rinsed with 190 jil incubation buffer and immediately centrifuged for 3.5 min at 400g. The eluates were counted for radioactivity.
[3H]LTC4 transport was performed as described above, except that the vesicles were filtered through nitrocellulose filters (0.22 jm pore size) presoaked with incubation buffer using a rapid filtration device (Leier et al, 1994b ).
Cytotoxicity tests
Cell proliferation was assayed according to Mosman (1983) , with modifications as described by Pourtier-Manzanedo et al (1991) . Cells that were normally cultivated under drug-selection pressure were washed and resuspended in fresh medium without the selecting agent 24 h before starting the experiment. Untreated cells and cells pretreated 24 h with 50 jM buthionine sulphoximine (BSO) were deposited in 96-well microtitre plates (3000 cells per well) and exposed to varying chlorambucil concentrations. Dimethyl sulphoxide (DMSO) was used to prepare a chlorambucil stock solution, this was diluted in medium according to the highest drug concentration and subsequently serially to the required concentrations. As a control, the highest DMSO concentration used in the assay was checked to ensure that it did not affect the measurements of chlorambucil cytotoxicity. After 3 days of incubation at 37°C/5% carbon dioxide, 100 jl of medium per well was removed and replaced with 20 jil of MTT (3-[4,5-dimethylthiazol-2-yl]2,5-diphenyl tetrazolium bromide; 2.5 mg ml-'). The plates were incubated for 2-3 h and the formazan crystals were dissolved by addition of 100 jil of 2-butanol-isopropanol-IM hydrochloric acid (16:8:1 v/v/v), shortly sonicated, mixed and the absorption was read at 570 nm. Cell viability is given by the relative absorption in per cent of cells grown without drug.
In contrast to melphalan, uptake of chlorambucil is not markedly influenced by the amino acids in the culture medium (Begleiter and Goldenberg, 1983) and was therefore chosen for the growth inhibition assay. The uptake of melphalan into intact cells can be inhibited by amino acids that are present in cell culture media at relatively high concentrations (Vistica, 1983) . As growth inhibition assays are performed in the presence of cell culture media, the presence of these amino acids would influence the uptake of melphalan and prevent a correct analysis of cytotoxicity.
Immunoblot
Membrane proteins were separated on a 7.5% acrylamide gel. Immunoblotting was performed essentially according to Towbin et al (1979) with a tank blotting system and ECL detection. The polyclonal antibody 6KQ was raised in rabbits against the carboxyl-terminal sequence of MRP1 (Krishnamachary et al, 1994) .
Reverse transcription PCR, cloning and sequence analysis Total RNA was isolated from CHO cells using the RNA-Clean System kit (Angewandte Gentechnologie Systeme, Heidelberg, Germany). Reverse transcription polymerase chain reaction (RT-PCR) analysis was performed as described (Mayer et al, 1995; Buchler et al, 1996) . The amplification proceeded through 35 cycles at 94°C for 1 min, 50°C for 1 min and 72°C for 1 min. Using the sense and anti-sense primers (ForIIIVRevIII), a 182-bp fragment complementary to a region in the first nucleotide binding domain of human MRP1 was amplified (Mayer et al, 1995) . Subsequently, the PCR fragment was subcloned into the pCRScript SK(+) plasmid (Stratagene, La Jolla, CA, USA) and integrated into competent E. coli. DNA sequencing was performed according to Sanger et al (1977) .
RESULTS
Identification and isolation of glutathione S-conjugated chlorambucil and melphalan HPLC separation and subsequent ESI-MS analysis demonstrated that chlorambucil and melphalan, in the presence of GSH and cytosol from GST-a-overexpressing CHO-Chlr cells, form covalent glutathione S-conjugates. Three different glutathione S-conjugates of these two nitrogen mustards can be produced: the monoglutathionyl S-conjugate, the monohydroxy glutathionyl S-conjugate and the bisglutathionyl S-conjugate (Dulik et al, 1986 (Dulik et al, , 1990 Ciaccio et al, 1990) . This is exemplified for chlorambucil in Figure 1 . Chlorambucil glutathione S-conjugates were separated using a two-step HPLC procedure. In step 1, monoglutathionyl chlorambucil, (M2, Figure lA and C) was separated from native chlorambucil (MI, Figure lA and B) and from monohydroxy monoglutathionyl chlorambucil and bisglutathionyl chlorambucil. The last two compounds were eluted in one peak ( Figure IA , M3 + M4) and were separated using a second HPLC system ( Figure ID-F) .
Using our HPLC system, only monoglutathionyl and hydroxy glutathionyl melphalan were isolated. Comparison of HPLC chromatograms of double-labelled melphalan glutathione S-conjugate and ESI-MS analysis confirmed the isolation of these two glutathione conjugates (not shown). On-line liquid chromatography-ESI-MS studies using a more polar column revealed that the bisglutathionyl melphalan S-conjugate was eluted in the aqueous phase of the gradient in the present system (not shown). Table 1 , for both chlorambucil and melphalan, the monoglutathionyl S-conjugates had higher transport rates than the bisglutathionyl and the monohydroxy monoglutathionyl conjugates. The transport rates of the glutathione S-conjugates in HeLa T5 membrane vesicles were at least five times higher than those measured in HeLa Cl membrane vesicles (Table 1 and Figure 2) 
Mrpl detection in CHO-Kl and CHO-Chir membrane vesicles
Immunodetection using the polyclonal antibody 6KQ directed against the carboxyl-terminal sequence of MRP1 (Krishnamachary et al, 1994) indicated that a 190-kDa hamster homologue of MRP1 is expressed in membranes of both CHO cell lines (Figure 3) . These results were confirmed by analysing the expression of the hamster homologue of MRPl by PCR amplification of cDNA reverse transcribed from CHO-KI and from CHO-Chlr cell mRNA and subsequent sequencing of the obtained 182-bp fragment. The amino acid sequence deduced from this fragment was 88% and 80% identical to and 93% and 88% similar to murine Mrpl (Stride et al, 1996) and human MRP1 (Cole et al, 1992 ) respectively (Figure 3) . The amino acid sequence excluding the primer regions (i.e. amino acids 720-760) was 85% and 73% identical to and 93% and 85% similar to murine Mrpl and human MRP1 respectively. This partial sequence was only 65% identical to and 75% similar to the rat canalicular Mrpl isoform (Biichler et al, 1996) (not shown).
British Journal of Cancer (1998) Figure 3 (A) Immunodetection of Mrpl in CHO-Kl and CHO-Chlr membranes using anti-MRP1 polyclonal antibody 6KQ (Krishnamachary et al, 1994) . Membrane proteins from CHO-K1, from CHO-Chlr and from HeLa T5 cells were analysed as described in Materials and methods. The amount of protein was loaded as indicated. (B) Amino acid sequence deduced from a 182-bp fragment of the hamster MRP1 homologue. Numbers indicate amino acid position of murine (Stride et al, 1996) as well as human MRP1 (Cole et al, 1992 Figure 4 and Table 2 ).
Growth inhibition assay of MRP1-expressing cell lines in the presence of chlorambucil and resistance modulation by buthionine sulphoximine pretreatment The resistance of HL60, GLC4, HeLa and CHO cell lines to chlorambucil was investigated. In the case of the HL60 and HeLa cell lines, the respective parental and MRP1-overexpressing cell lines were similarly sensitive to chlorambucil with resistance factors (RF) close to 1 (Table 3) . The GLC4 and GLC4/ADR cell line pair, however, differed in its IC50 values (Table 3 ) with a RF for the GLC4/ADR cells of 2.5. This RF was reduced by 28% when these cells were pretreated for 24 h with 50 gM BSO. The CHO cell line pair showed a marked difference in resistance with the RF for the CHO-Chlr equal to 5.6 (Table 3) . Pretreatment of the CHO cell lines with BSO reduced the resistance factor of the CHO-Chlr by 40% (Table 3) . DISCUSSION MRP1, a 190-kDa membrane glycoprotein conferring resistance of cells to several structurally unrelated cytostatic drugs (Zaman et al, 1995; Loe et al, 1996c) , has been shown to be a high-affinity export pump for several glutathione S-conjugates (Jedlitschky et al, 1994 Leier et al, 1994a Leier et al, , 1996 Muller et al, 1994) . We demonstrate in the present study that the various glutathione S-conjugates of chlorambucil and melphalan are substrates for human MRP1 using membrane vesicles prepared from MRPI-transfected cells (Table 1 and Figure 1 ). However, differences in functional groups or hydrophobicity modify the transport rates. Monoglutathionyl chlorambucil was a better substrate than monohydroxy glutathionyl chlorambucil, with a 22-fold higher initial transport rate (Table 1) . Moreover, the initial transport rate of monoglutathionyl melphalan was 3.7-fold higher than that of monohydroxy monoglutathionyl melphalan (Table 2 ). Also noteworthy is that the number of glutathione moieties conjugated to a compound affects the transport rate. Bisglutathionyl chlorambucil, for instance, was a poorer MRP1 substrate than monoglutathionyl chlorambucil but better than monohydroxy monoglutathionyl chlorambucil (Table 1) . Native chlorambucil, which is itself an amphiphilic anion, was not a substrate for MRP1; also, in the presence of GSH, no transport of this drug was detected. Under the same condition, we were able to measure vincristine transport as it was previously described by Loe et al (1996b) . Native melphalan, which is a zwitterion at physiological pH, was not found to be a MRP1 substrate (Table 1) . This indicates that conjugation of these alkylating agents to glutathione is necessary for their export from cells. So far no cross-resistance of MRP1-overexpressing cells to chlorambucil and melphalan has been described. The finding that the control CHO-Ki as well as the chlorambucil-resistant CHOChlr cells overexpressing GST-a (Lewis et al, 1988) express the hamster homologue of MRP1 (Figure 3) provided a means to investigate the role of MRP1 in cells selected for resistance to chlorambucil. The detection of Mrpl expression in the CHO-KI cells confirms an earlier speculation by Turner and Curtin (1996) .
British Journal of Cancer (1998) Transport rates of monoglutathionyl chlorambucil and leukotriene C4 (LTC4) were higher in the CHO-Chlr than in the CHO-KI membrane vesicles (Table 2 and Figure 4 ). In concordance with the transport data, the CHO-Chlr membranes showed a slightly more intense signal in the immunodetection of the hamster homologue of MRP1 than the CHO-Kl membranes (Figure 3 ). The resistance of the CHO-Chlr cells to chlorambucil indicates that the low amount of hamster Mrpl present in these cells, compared with the MRPI-overexpressing human cells, is sufficient to mediate the export of the glutathione S-conjugates of these alkylating agents. Among the human MRP1-overexpressing cells tested in the present study, only the GLC4/ADR cells showed an enhanced chlorambucil resistance compared with their respective parental cell line (Table 3) , despite the fact that the glutathione S-conjugates of chlorambucil and melphalan were also transported into membrane vesicles of the other MRPl-overexpressing cells used (Table 1 and Figure 2 ). The modulation of resistance of the GLC4/ADR cell line to chlorambucil by pretreatment with BSO (Table 3) underlines that the conjugation to glutathione is a necessary step in the resistance mechanism to this agent in this cell line. An increased requirement for GSH necessitates an increase in its synthesis and recycling. Consequently, all GSH-related synthetic and conjugating enzymes are crucial in this type of resistance (O'Brien and Tew, 1996) . As a measure of MRP1 activity, transport of the high-affinity substrate LTC4 can be used (Jedlitschky et al, 1994; Leier et al, 1994a; Muller et al, 1994) . LTC4 transport rates have been determined to be 25-fold higher in HL60/ADR (Jedlitschky et al, 1994) , tenfold higher in HeLa T5 (Leier et al, 1994a) and eightfold higher in GLC4/ADR (Muller et al, 1994) than those measured in the membrane vesicles of the respective parental cell lines. In the present investigation, however, from these cell lines only the GLC4/ADR cells showed a resistance factor against chlorambucil of about 2.5. The resistance factors of the other two cell lines were close to 1 (Table 3 ). The resistance factor for CHO-Chlr cells to chlorambucil was significantly higher (Table 3 ) but LTC4 transport activity was only 15-30% of that observed in the MRP1-overexpressing cells (Table 2 ; Jedlitschky et al, 1994; Leier et al, 1994a) . Thus, increased transport of glutathione S-conjugates does not necessarily indicate increased resistance to the bifunctional alkylating agents.
Our results underline the broad substrate specificity of MRP1. In addition, for the alkylating agents studied, conjugation to glutathione, rather than MRP1 activity, appears to be the ratelimiting step in their detoxification.
